Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors.

about

Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors.

Item

http://www.wikidata.org/entity/Q49266925

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Characterization of 111In-labe ...... cer for Neuroendocrine Tumors.

@en

Characterization of 111In-labe ...... cer for Neuroendocrine Tumors.

@nl

type

Item

label

Characterization of 111In-labe ...... cer for Neuroendocrine Tumors.

@en

Characterization of 111In-labe ...... cer for Neuroendocrine Tumors.

@nl

prefLabel

Characterization of 111In-labe ...... cer for Neuroendocrine Tumors.

@en

Characterization of 111In-labe ...... cer for Neuroendocrine Tumors.

@nl

P1476

Characterization of 111In-labe ...... cer for Neuroendocrine Tumors.

@en

P2093

Lieke Joosten

http://www.w3.org/2001/XMLSchema#string

Martin Gotthardt

http://www.w3.org/2001/XMLSchema#string

Stefanie M A Willekens

http://www.w3.org/2001/XMLSchema#string

P2860

Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin

The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging—first preclinical studies.

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting.

Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes.

Peptide receptors as molecular targets for cancer diagnosis and therapy.

Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice.

Internalization and desensitization of the human glucose-dependent-insulinotropic receptor is affected by N-terminal acetylation of the agonist.

Development and clinical application of peptide-based radiopharmaceuticals.

P2888

s41598-018-21259-3

P304

2948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-21259-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maarten Brom

Otto C. Boerman

P577

2018-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100901840

http://www.w3.org/2001/XMLSchema#string

P698

29440684

http://www.w3.org/2001/XMLSchema#string

P932

5811606

http://www.w3.org/2001/XMLSchema#string